Physician
Rheumatology
Dr. Elizabeth C. Hsia, MD
|
|
Give Review
Elizabeth C. Hsia, MD is an expert in the field of Rheumatology. She attended Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. She over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow" and "Fellow (FACR)". Elizabeth Hsia is a published doctor as well. She has 34 publications published. The latest was: Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial.
Publications
- Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial.
- Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirhe...
- Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid Arthritis who discontinued prior anti-tumour necrosis factor therapy: post...
- Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled ...
- Effect of golimumab on carotid atherosclerotic Disease measures and cardiovascular events in inflammatory arthritides.
- Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients w...
- The effect of golimumab on haemoglobin levels in patients with rheumatoid Arthritis, psoriatic Arthritis or ankylosing spondylitis.
- Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid Arthritis: secondary analysis from a large clinical trial.
- Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension.
- Evaluation of Serum Biomarkers Associated with Radiographic Progression in Methotrexate-naive Rheumatoid Arthritis Patients Treated with Methotrexate or Golimumab.
- A comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-TNF antibody, in phase 3 clinical trials.
- Interferon-gamma release assay versus tuberculin skin test across RA, PsA, and AS patients prior to treatment with golimumab, a human anti-TNF antibody.
- Reply to letter to the editor regarding "The effect of golimumab on radiographic progression in rheumatoid Arthritis:
- Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnet...
- Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid Arthritis.
- Assessment by MRI of inflammation and damage in rheumatoid Arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
- Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid Arthritis: results of an analysis of the literature over the past 16 y...
- The effects of golimumab on radiographic progression in rheumatoid Arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and gol...
- Diabetes mellitus and insulin resistance in patients with rheumatoid Arthritis: Risk reduction in a chronic inflammatory disease.
- Diabetes and insulin resistance in patients with rheumatoid Arthritis: Risk reduction in a chronic inflammatory disease.
- Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active Rheumatoid...
- Golimumab in patients with active rheumatoid Arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.
- Analysis of a cluster of cases of Wegener granulomatosis.
- Management of aortic Disease in Marfan Syndrome: a decision analysis.
- Predictive factors in early Arthritis: long-term follow-up.
- Evaluating treatment efficacy: potential biases behind randomized controlled trials.
- Cost-effectiveness analysis of the Lyme Disease vaccine.
- Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid Arthritis despite methotrexate therapy: th...
- TNF involvement and anti-TNF therapy of reactive and unclassified Arthritis.
- Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated Arthritis: an open-label trial.
- Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid Arthritis despite receivi...
- Golimumab in patients with active rheumatoid Arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double...
- Golimumab in patients with active rheumatoid Arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.
Schools
Yale University School Of Medicine
Hospital Of University Of Pa
Conditions Treated
- Arthritis
- Behçet's Disease
- Fibromyalgia
- Gout
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow
- Fellow (FACR)
Education
-
University of Pennsylvania Health System -
Yale University School of Medicine
Hospital
-
Penn Presbyterian Medical Center -
Hospital of the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Jake E. Ritt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason G. Lieberthal, MD |
|
|
Dr. Terri M. Laufer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geo S. Derimanov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chadwick R. Johr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Eisenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaishree Manohar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Humaira N. Adenwalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele Meltzer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antoine G. Sreih, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steffan W. Schulz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chris T. Derk, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|